At Reproductive Medicine Associates of New York (RMA of New York), our team of physicians stands committed to advancing research in the field of assisted reproductive technology, and combines fertility education with cutting edge treatments to maximize success rates for our patients. Our team of physicians and embryologists use evidence-based, data-driven precision medicine, combining 15 years of patient-specific data with hundreds of years of combined clinical expertise to diagnose and treat women experiencing infertility or seeking fertility preservation options.
Our dedication to medical excellence is exemplified through extensive training and education provided to our staff who in turn partner with patients to achieve positive reproductive outcomes. The RMA of New York team integrates and applies the most modern technologies available in reproductive medicine. The clinical team combines personalized and patient-centered care with cutting edge technologies including embryo biopsy and screening via comprehensive chromosomal screening (CCS) with next-generation sequencing followed by elective single embryo transfer (eSET) to reduce risk of chromosomal abnormalities, miscarriages and multiple gestation.
Over the last several years our experience has shown that optimal success rate for embryo implantation occurs when an embryo is transferred into a prepared endometrium. For the first several decades of in vitro fertilization, it was common to retrieve, fertilize and then transfer the best embryo or embryos into the uterus. The problem with performing a fresh embryo transfer is that the endometrium is often advanced and the chance of a successful implantation could be compromised. Now that we are routinely genetically screening embryos prior to transfer and have data to support our medical decisions, it is clear that transferring an embryo into a prepared endometrium gives it a much greater chance of surviving and becoming a healthy ongoing pregnancy. Freezing and thawing technologies have improved greatly, and as a result we are experiencing a 98% embryo survival rate with vitrification and rewarming. The additional several weeks added to an IVF cycle by implementing modern IVF technologies including biopsy, freezing, and thawing, is a minimal cost when weighed against higher success rates, lower miscarriage rates, and healthier babies.
Advantages to using frozen vs fresh embryo transfer include:
Our established peer-recognized team consistently provides technical and clinical innovation to ensure our patients are able to benefit from the very latest procedures in the field of fertility. Our physicians and embryology teams use advanced technology to increase implantation rates, reduce miscarriage rates and increase live birth rates, as evidenced by our success rates well above the national average.
What gives us a leading advantage?
RMA of New York offers patients personalized, compassionate, premium quality care. As the Division of Reproductive Endocrinology and Infertility of Mount Sinai Hospital, our team is dedicated to scientific discovery, graduate medical education, and patient focused care. We are proud to be a member of the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai and of recognition as a Center of Excellence by US News & World Report. The size and scale of the Mount Sinai Health System provides our patients with access to 6,455 primary and specialty care physicians, in addition to 6,000 nurses and 2,000 residents and fellows.
RMA of New York nurses, physicians, and team members provide personalized care to each and every individual. We specialize in meticulous attention to providing personalized, patient-focused care and are culturally and religiously sensitive to meet the needs of individuals and couples visiting from across the globe. Our multi-lingual staff has assisted patients from over 150 countries to date in the most cost-effective and time-efficient manner.
RMA of New York’s leading advantage is evident in our ability to work with patients who have a history of IVF failures at other centers, as well as those with poor prognoses. We are recognized as a global leader in fertility preservation, and for more than a decade have successfully performed egg freezing for social and medical indications. Our team is committed to improving reproductive outcomes by performing advanced research in laboratory processes, quality controls, data-driven protocols, and scientific discovery. This commitment is proven by our team which includes multiple physicians recognized on New York magazine’s “Best Doctors” list for over 15 years.
Single vs. Multiple Embryo Transfer By: Matthew A. Lederman, MD In vitro fertilization (IVF) has evolved dramatically over the last few decades, with more than six million babies now born through assisted reproductive technology. For years, multiple embryos were transferred to the uterus in hopes ...READ MORE
to receive all the latest News, Events & MORE!